Perhaps you are unfamiliar with medical research but stating that available data is poor quality is an objective assessment. I provided a brief explanation in parentheses which you excluded for some reason.
I also provided a reference that is open access but here is the relevant section for you:
In Canada, there are no national data on the incidence or prevalence of silicosis. In the province of Alberta, where silicosis is a notifiable disease, health insurance data revealed 861 cases with at least one reported diagnosis of ‘silicosis’ during a period of 10 years from 2000. These results were based on raw data and not a secondary review of primary imaging and clinical information. Data from 2000 through 2009 showed that only 29 workers' compensation claims were accepted for silicosis in Alberta. Data from Quebec's compensation system revealed 351 compensated cases of silicosis between 1988 and 1998. Of note, workers who participated in regular surveillance had milder disease at the time of compensation.
The JAMA study is from 2019-2022. Data that is 20-30 years old is relatively poor quality.
Changes in medicine, workplace safety rules and occupational trends makes it hard to compare to silicosis rates in Canada to the US in order to assess the claims of the comment I replied to therefore I think the relative incidence described in this review article (from 2022) is inaccurate.
If you want to disregard my quality assessment, the discussion ends with the review article showing silicosis rates are 3x higher in Canada.
Can you elaborate on how any of this shows I have an axe to grind or that I’m biased?
I also provided a reference that is open access but here is the relevant section for you:
In Canada, there are no national data on the incidence or prevalence of silicosis. In the province of Alberta, where silicosis is a notifiable disease, health insurance data revealed 861 cases with at least one reported diagnosis of ‘silicosis’ during a period of 10 years from 2000. These results were based on raw data and not a secondary review of primary imaging and clinical information. Data from 2000 through 2009 showed that only 29 workers' compensation claims were accepted for silicosis in Alberta. Data from Quebec's compensation system revealed 351 compensated cases of silicosis between 1988 and 1998. Of note, workers who participated in regular surveillance had milder disease at the time of compensation.
The JAMA study is from 2019-2022. Data that is 20-30 years old is relatively poor quality.
Changes in medicine, workplace safety rules and occupational trends makes it hard to compare to silicosis rates in Canada to the US in order to assess the claims of the comment I replied to therefore I think the relative incidence described in this review article (from 2022) is inaccurate.
If you want to disregard my quality assessment, the discussion ends with the review article showing silicosis rates are 3x higher in Canada.
Can you elaborate on how any of this shows I have an axe to grind or that I’m biased?